ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 68 filers reported holding ALLAKOS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,299 | -47.9% | 3,656 | 0.0% | 0.00% | -100.0% |
Q2 2023 | $15,940 | -82.2% | 3,656 | -60.1% | 0.00% | 0.0% |
Q4 2021 | $89,784 | -90.8% | 9,171 | 0.0% | 0.00% | -92.9% |
Q3 2021 | $970,934 | +18.3% | 9,171 | -4.6% | 0.01% | +16.7% |
Q2 2021 | $820,833 | +0.6% | 9,615 | +35.3% | 0.01% | 0.0% |
Q1 2021 | $815,971 | -21.4% | 7,109 | -4.2% | 0.01% | -25.0% |
Q4 2020 | $1,038,520 | +70.3% | 7,418 | -0.9% | 0.02% | +45.5% |
Q3 2020 | $609,653 | +13.3% | 7,485 | 0.0% | 0.01% | +10.0% |
Q2 2020 | $537,872 | +105.3% | 7,485 | +27.1% | 0.01% | +66.7% |
Q1 2020 | $262,046 | -53.3% | 5,890 | 0.0% | 0.01% | -33.3% |
Q4 2019 | $561,670 | +17.7% | 5,890 | -2.9% | 0.01% | +12.5% |
Q3 2019 | $477,205 | +113.7% | 6,069 | +17.8% | 0.01% | +100.0% |
Q2 2019 | $223,323 | +11.8% | 5,154 | +4.5% | 0.00% | 0.0% |
Q1 2019 | $199,706 | +29.0% | 4,931 | +66.5% | 0.00% | +33.3% |
Q4 2018 | $154,771 | -22.9% | 2,961 | -33.6% | 0.00% | -25.0% |
Q3 2018 | $200,700 | – | 4,461 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 270,965 | $12,055,000 | 6.94% |
NEA Management Company, LLC | 2,268,188 | $100,912,000 | 5.27% |
Fairmount Funds Management LLC | 178,662 | $7,949,000 | 4.82% |
Redmile Group, LLC | 2,976,928 | $132,444,000 | 3.71% |
Boxer Capital, LLC | 675,000 | $30,031,000 | 2.05% |
Rock Springs Capital Management LP | 235,000 | $10,455,000 | 0.43% |
Cormorant Asset Management, LP | 200,000 | $8,898,000 | 0.41% |
RAMIUS ADVISORS LLC | 31,155 | $1,386,000 | 0.35% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 15,700 | $692,000 | 0.32% |
Handelsinvest Investeringsforvaltning | 20,000 | $890,000 | 0.24% |